Zydus Lifesciences gets USFDA nod for generic acne-treating drug
Zydus Lifesciences received final approval from the US health regulator for its generic antibiotic Minocycline Hydrochloride extended-release tablets used for treatment of moderate to severe acne, the company said in a regulatory filing on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 19, 2023 Category: Pharmaceuticals Source Type: news

Patient's tongue turns 'BLACK and hairy' because of rare reaction to a common antibiotic
The patient, in her 60s and from Japan, was taking minocycline to counter the side effects of her chemotherapy. Doctors also claimed she had developed grey skin on her face. (Source: the Mail online | Health)
Source: the Mail online | Health - May 10, 2023 Category: Consumer Health News Source Type: news

Efficacy of adjunctive measures in the non-surgical treatment of peri-implantitis: A systematic review
Conclusions: Different adjunctive measures in the non-surgical treatment of peri-implantitis have different impact in terms of PD and BoP reductions. Improved PD reductions result after the use of systemic antimicrobials, and to a lesser extent, after the use of local antimicrobials. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 9, 2023 Category: Dentistry Source Type: news

Minocycline Doesn't Slow Geographic Atrophy in AMD Minocycline Doesn't Slow Geographic Atrophy in AMD
A potential drug for age-related macular degeneration failed to slow geographic atrophy, according to data from a long-term study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2023 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Minocycline Oral, Injection products
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Adjunct Minocycline Shows No Benefit in Treatment-Resistant Depression
(MedPage Today) -- Adjunctive minocycline provided similar outcomes as placebo for people with treatment-resistant depression, the MinoTRD randomized clinical trial showed. Treatment with minocycline, a tetracycline antibiotic, did not show a... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 16, 2022 Category: Psychiatry Source Type: news

A'Setback' for Anti-inflammatory Treatment in Depression A'Setback' for Anti-inflammatory Treatment in Depression
Adding minocycline to standard antidepressant therapy did not alter the overall course of treatment-resistant depression in the largest study to date of the therapy.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 15, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news

Adjunct Minocycline No Benefit for Treatment - Resistant Depression
No alteration of course of depression seen over six weeks of treatment compared with placebo (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 15, 2022 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

Adjunct Minocycline No Benefit for Treatment-Resistant Depression
WEDNESDAY, Sept. 14, 2022 -- For patients with treatment-resistant depression (TRD), minocycline as add-on to antidepressant treatment as usual does not reduce depressive symptoms, according to a study published online Sept. 14 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2022 Category: Pharmaceuticals Source Type: news

minocycline
Title: minocyclineCategory: MedicationsCreated: 7/29/2022 12:00:00 AMLast Editorial Review: 7/29/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 29, 2022 Category: Drugs & Pharmacology Source Type: news

Zilxi (minocycline)
Title: Zilxi (minocycline)Category: MedicationsCreated: 9/9/2021 12:00:00 AMLast Editorial Review: 9/9/2021 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 9, 2021 Category: Dermatology Source Type: news

Dynacin (Minocycline Hydrochloride Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 22, 2021 Category: Drugs & Pharmacology Source Type: news

Dynacin (Minocycline Hydrochloride Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 15, 2021 Category: Drugs & Pharmacology Source Type: news

Zilxi (Minocycline Topical Foam) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 11, 2021 Category: Drugs & Pharmacology Source Type: news

HEALTH NOTES: Antibiotics 'help treat depression'
HEALTH NOTES: Doctors in South London recruited 39 patients suffering 'treatment-resistant' depression and gave half of them the antibiotic minocycline. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2021 Category: Consumer Health News Source Type: news